Cutting Medicare Prescription Drug Prices in Half Act
- Introduced May 4
- Committee May 4
- Passed Senate Next
- Passed House Not yet
- To President Not yet
- Law Not yet
Where it stands
In committee, May 4, 2023Next: Senate vote
1273d ago May 4, 2023: Read twice and referred to the Committee on Finance.
Final votes
No roll callsNo recorded vote on this bill yet
Member trades
0trades in the last 90 days
None in these companies
Who backs the bill and who pushes back Subscribe
Companies lobbying on this bill
1 companyCompanies by sector
Biotech & Pharma 1
Search all 1 companies, their asks and price moves Subscribe
Votes
No recorded roll-call vote on this bill yet
Member trades
No member of Congress traded these companies in the last 90 days
Summary
Cutting Medicare Prescription Drug Prices in Half Act
Full summary1 paragraphs
This bill caps the cost of prescription drugs under Medicare at the amount that the Department of Veterans Affairs or the General Services Administration pays for the drug, whichever is lower.
Library of Congress summary, May 4, 2023
Summary versions
- Introduced in SenateMay 4, 2023
Actions
- SenateIntroduced in SenateMay 4, 2023
- SenateRead twice and referred to the Committee on Finance.May 4, 2023
Bill record
Text versions1
- Introduced in SenateMay 4, 2023PDF: Introduced in Senate
Committees1
- Senate Finance CommitteeReferred To May 4, 2023
Sponsor and cosponsors1 cosponsor
- Sen. Bernard Sanders (I-VT)Sponsor, May 4, 2023
- Amy Klobuchar (D-MN)OriginalJoined May 4, 2023
Amendments0
No amendments offered
Cost estimates and reports0
No cost estimate or committee report yet
Titles2
Short titles
- Cutting Medicare Prescription Drug Prices in Half ActShort Title(s) as Introduced
Official titles
- A bill to establish a cap on costs for covered prescription drugs under Medicare parts B and D.Official Title as Introduced
Subjects1
Policy area
Related bills1
- S. 3615 117th, Reintroduction of Cutting Medicare Prescription Drug Prices in Half Act
Official record from Congress.gov, the House Clerk and the Senate; lobbying from Lobbying Disclosure Act filings. Updated Oct 27, 2026.